Table 1.
Demographic and clinical information for HIV− and HIV+ adults
| Variable | HIV+ (n = 307) | HIV− (n = 183) | p |
|---|---|---|---|
| Age (years) | 49.6 (12.2) | 47.7 (15.7) | 0.667 |
| Gender (% men) | 85.7 | 67.2 | < 0.0001 |
| Handedness (% right) | 91.2 | 89.1 | 0.438 |
| Education (years) | 13.6 (2.5) | 14.2 (2.6) | 0.031 |
| Hollingshead Highest Occupation | 5.6 (1.7) | 5.6 (1.8) | 0.704 |
| Race/Ethnicity (%) | 0.148 | ||
| Caucasian | 57.3 | 59.1 | |
| African American | 22.8 | 16.9 | |
| Hispanic | 17.9 | 19.1 | |
| Other | 2.0 | 4.9 | |
| Major Depressive Disorder (%) | < 0.0001 | ||
| Current | 13.7 | 3.3 | |
| Lifetime | 62.9 | 33.9 | |
| Generalized Anxiety Disorder (%) | < 0.0001 | ||
| Current | 4.9 | 0.0 | |
| Lifetime | 17.9 | 3.8 | |
| Substance Use Disorder (%)b | 73.0 | 59.6 | 0.002 |
| Global Deficit Score (GDS) e | 0.23 (0, 0.54) | 0.15 (0, 0.33) | 0.005 |
| Medical | |||
| Hepatitis C Infection (HCV,%) | 22.3 | 10.4 | 0.001 |
| Estimated duration of infection (years) | 15.8 (9.5) | -- | |
| Plasma HIV RNA (rnlog10) a | 1.6 (1.6, 1.7) | -- | |
| Current CD4 count (cells/μL) a | 583 (400, 784) | -- | |
| Nadir CD4 count (cells/μL) a | 186 (63, 300) | -- | |
| AIDS (%) | 57.7 | -- | |
| Antiretroviral therapy (% prescribed) | 90.2 | -- |
Note. Data represent M (SD) or valid population % values. HIV = Human Immunodeficiency Virus; CD4 = cluster of differentiation.
Based on median and interquartile range (IQR) scores
Based on lifetime prevalence (no participants met criteria for current Substance Use Disorder)